» Articles » PMID: 35465427

Does Chronic Kidney Disease Really Affect the Complications and Prognosis After Liver Resection for Hepatocellular Carcinoma? A Meta-Analysis

Overview
Journal Front Surg
Specialty General Surgery
Date 2022 Apr 25
PMID 35465427
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this meta-analysis was to analyze whether chronic kidney disease (CKD) affected the complications and prognosis after liver resection for hepatocellular carcinoma.

Methods: The PubMed, Embase, and Cochrane Library databases were searched from inception to 22 February 2022 to find eligible studies. Complications, overall survival (OS), and disease-free survival (DFS) were collected, and this meta-analysis was performed with RevMan 5.3.

Results: A total of nine studies including 6,541 patients were included in this meta-analysis. After pooling all baseline information, the CKD group had a higher rate of Child-Pugh grade B than the Non-CKD group (OR = 1.58, 95% CI = 1.3 to 1.93, < 0.00001). As for surgery-related information, the CKD group had larger blood loss (MD = -404.79, 95% CI = -509.70 to -299.88, < 0.00001), and higher rate of blood transfusion (OR = 2.47, 95% CI = 1.85 to 3.3, < 0.00001). In terms of complications, the CKD group had a higher rate of overall complications (OR = 2.1, 95% CI = 1.57 to 2.81, < 0.00001) and a higher rate of ≥ grade III complications (OR = 2.04, 95% CI = 1.57 to 2.81, = 0.0002). The CKD group had poor OS compared with the non-CKD group (HR = 1.28, 95% CI = 1.1 to 1.49, = 0.001). However, in terms of DFS, no significant difference was found (HR = 1.11, 95% CI = 0.96 to 1.28, = 0.16).

Conclusion: Preexisting CKD was associated with higher ratio of complications and poor OS.

Citing Articles

Impact of red blood cell distribution width (RDW) on postoperative outcomes in hepatocellular carcinoma (HCC) patients.

Li J, Xu Y, Tan S, Wang Z Medicine (Baltimore). 2024; 103(24):e38475.

PMID: 38875439 PMC: 11175885. DOI: 10.1097/MD.0000000000038475.


Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.

Vaghiri S, Lehwald-Tywuschik N, Prassas D, Safi S, Kalmuk S, Knoefel W Langenbecks Arch Surg. 2024; 409(1):149.

PMID: 38698255 PMC: 11065924. DOI: 10.1007/s00423-024-03337-5.


Should we change the treatment plan in early hepatocellular carcinoma with chronic kidney disease?.

Chao W, Chai S, Chiang P, Chou T, Chen Y, Soong R BMC Surg. 2023; 23(1):83.

PMID: 37041544 PMC: 10091604. DOI: 10.1186/s12893-023-01983-y.

References
1.
Orii T, Takayama T, Haga I, Fukumori T, Amada N . Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure. Surg Today. 2008; 38(4):329-34. DOI: 10.1007/s00595-007-3634-1. View

2.
Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

3.
Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J . Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. World J Urol. 2017; 36(2):249-256. DOI: 10.1007/s00345-017-2141-2. View

4.
Yoshikawa T, Nomi T, Hokuto D, Kamitani N, Matsuo Y, Sho M . Outcomes in Patients with Chronic Kidney Disease After Liver Resection for Hepatocellular Carcinoma. World J Surg. 2020; 45(2):598-606. DOI: 10.1007/s00268-020-05829-z. View

5.
Clark T, Maximin S, Meier J, Pokharel S, Bhargava P . Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment. Curr Probl Diagn Radiol. 2015; 44(6):479-86. DOI: 10.1067/j.cpradiol.2015.04.004. View